MMR Panel by IHC (MLH1, MSH2, MSH6, PMS2)
Methodology
Immunohistochemistry (IHC)
Test Description and clinical significance
Disease:
Lynch syndrome, carcinomas of the rectum, colon, small intestine and stomach to screen for: Lynch syndrome MSI high neoplasms, endometrial carcinomas, endometrioid, clear cell and mucinous carcinoma of the ovary
Immunohistochemistry for the MMR proteins MLH1, PMS2, MSH2 and MSH6
Specimen Requirements
Collection:
FFPE/un-stained slides/Fresh tissue in formalin
Stability:
Room temperature
Unacceptable Conditions:
Unlabeled specimen/specimen left unfixed
for extended periods
Storage & Transport
Room Temperature
CPT(s)
88342, 88341x3
New York Approved
NO
*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.
